Protection of the Patient in Radionuclide Investigations: A Report Prepared for the International Commission on Radiological Protection, Issue 17
International Commission on Radiological Protection, 1971 - Radiopharmaceuticals - 84 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Availability of substitute elements or compounds
Requirement of test
6 other sections not shown
20 iCi/test Age mrad//iCi References Age Organ Age Average whole body biological half-life Chlormerodrin Christchurch clin dose received Dose with Age E. W. and Robinson Female gonad Foetal thyroid G. A. and Harris gonad Harvard Medical School iCi/test ICRP Publication Intravenous Organ mrad//iCi Intravenous Typical Iodine J. G. and Saenger Kereiakes Liver Scan M.R.C. panel McEwan Medical Isotope Scanning metabolism Minski mrad//iCi Reference Blood mrad//iCi References Average mrad//iCi References Bone mrad//iCi References Kidney mrad//iCi References Liver mrad//iCi References Lung mrad//iCi References Spleen mrad//iCi References Thyroid mrad/nCi National Radiation Laboratory nucl Nuclear Medicine nuclide Oral Organ mrad//iCi Organ Age mrad//iCi Organ Dose Organ mrad//iCi References pharmaceuticals radiation dose Radioisotope Radiol radionuclides rebreathing References Average whole Report from Harvard Scan Typical Scintigraphy submitted to M.R.C. Technetium tissue Typical 5 iCi/test Typical 50 University of London Unpublished calculation submitted uptake Variation of Organ Vennart Vitamin B12